Evidence map›Paper›PMID 40491546›Full record

ArticleInfection prevention in practice2025

Incidence of nosocomial pneumonia in two intensive care units of a French University Hospital from 2016 to 2022 in the era of COVID-19 pandemic.

Sélilah Amour, Elisabetta Kuczewski, Elodie Marion, Laurent Argaud, Julien Crozon-Clauzel, Anne Claire Lukaszewicz, Philippe Vanhems, Nagham Khanafer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection prevention in practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sélilah AmourUnité d'Epidémiologie et Biomarqueur de l'infection, Hôpital Edouard Herriot, Groupement Hospitalier Centre, Hospices Civils de Lyon, 69003 Lyon, France.
Elisabetta KuczewskiUnité d'Hygiène, Epidémiologie et Prévention, Hôpital Edouard Herriot, Groupement Hospitalier Centre, Hospices Civils de Lyon, 69003 Lyon, France.
Elodie MarionUnité d'Hygiène, Epidémiologie et Prévention, Hôpital Edouard Herriot, Groupement Hospitalier Centre, Hospices Civils de Lyon, 69003 Lyon, France.
Laurent ArgaudMedical Intensive Care Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, 69003 Lyon, France.
Julien Crozon-ClauzelAnaesthesia and Critical Care Medicine Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, 69002 Lyon, France.
Anne Claire LukaszewiczAnaesthesia and Critical Care Medicine Department, Hôpital Edouard Herriot, Hospices Civils de Lyon, 69002 Lyon, France.
Philippe VanhemsPublic Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID), Centre International de Recherche en Infectiologie (CIRI), Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.
Nagham KhanaferPublic Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID), Centre International de Recherche en Infectiologie (CIRI), Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hospital-Acquired Pneumonia (HAP) are common in intensive care units (ICUs). The COVID-19 pandemic led to a global increase in healthcare-associated infections (HAI) among ICU patients. The aim of this study was to evaluate the trends in HAP incidence over a seven-year period of surveillance in two ICUs at a French University Hospital, and to assess the impact of COVID-19 (as well as the associated bacterial ecology). Methods: A prospective surveillance of HAI in ICUs was conducted during the 1 Results: 1,797 patients were included, with 61.3% of male and a median age of 67 years. The median duration of intubation was 4 days (7 days in 2021 and 5 days in 2022). The proportion of COVID-19 patients was 45.7% in 2021 and 24.1% in 2022. Compared to 2020, the incidence of HAP increased in both 2021 [cIRR: 2.34 (95%CI: 1.30-4.23) and aIRR: 2.26 (95%CI: 1.25-4.08)] and 2022 [cIRR: 1.79 (95%CI: 0.97-3.32) and aIRR: 1.66 (95%CI: 0.90-3.07)]. The most commonly identified microorganisms were Enterobacteriaceae (42.4%), with a significantly higher incidence of HAP due to Enterobacteriaceae in COVID-19 patients. Conclusions: These results indicate an increase of HAP incidence in 2021 and 2022, mainly caused by

Indexed as

COVID-19 pandemicEnterobacteriaceaeHospital-acquired pneumoniaIntensive care unitsVentilator-acquired pneumonia

Identifiers

PMID40491546
PMCPMC12147891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.